Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

Hypertension affects 1 in 8 adults aged between 20 and 40 years. The prevalence of hypertension among adults in India is ...

Alembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride ...

Alembic Pharmaceuticals received final USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules, designed to treat hypertension. Available in multiple strengths, these capsules ...

These capsules will be available in dosages of 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, offering a generic alternative to ...

Alembic has a cumulative total of 218 ANDA approvals (191 final approvals and 27 tentative approvals) from USFDA, it added.

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Gossamer Bio (GOSS – Research Report). The associated ...

Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports.

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...

Cardio Shield is a natural remedy for blood pressure control. According to its manufacturer, the supplement helps lowe ...

Having kidney diseases can worsen diabetes. And it is true the other way around as well. Moreover, health experts say that managing both becomes extremely tough when an individual has both.

High blood pressure, or hypertension, is a common health issue affecting millions of people worldwide. It can often be ...